| 标题 |
An Innovative Approach to Optimize First-In-Human Minimal Anticipated Biological Effect Level Based Starting Dose in Oncology Trials for Bispecific T-Cell Engagers: Experience from A Solid Tumor Bispecific T-Cell Engager |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clin Pharmacol Ther 作者:Zhou D, Kischel R, Stienen S, Townsley D, Sternjak A, Lutteropp M, Bailis J, Friedrich M, Rattel B, Mehta K, Upreti VV 出版日期:2024-09-16 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)